clinical trials

Aldeyra reports positive data from dry eye disease therapy trial
Clinical Trials Arena
Wed, 03/1/23 - 10:08 am
Aldeyra Therapeutics
clinical trials
reproxalap
dry eye disease
CSL's Phase 3 Study Shows First-In-Class Garadacimab Provides Patients with Significant HAE Attack Prevention with Monthly Dosing
Drugs.com
Wed, 03/1/23 - 10:07 am
CSL
clinical trials
garadacimab
HAE
23andMe doses first patient in ph2a anti-tumour monotherapy
Pharmaphorum
Wed, 03/1/23 - 09:48 am
23andMe
clinical trials
solid tumors
23ME-00610
Merck reports two Phase 3 study misses for Keytruda
BioPharma Dive
Tue, 02/28/23 - 10:43 pm
Merck
clinical trials
Keytruda
prostate cancer
lung cancer
Acumen reveals late-stage clinical trial plans in early Alzheimer’s disease
Clinical Trials Arena
Tue, 02/28/23 - 11:02 am
Acumen Pharmaceuticals
clinical trials
Alzheimer's disease
ACU193
monoclonal antibodies
Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market
Fierce Biotech
Tue, 02/28/23 - 10:03 am
Junshi Biosciences
Amgen
Sanofi
China
clinical trials
PCSK9 inhibitors
Axsome says FDA wants more data for Alzheimer’s agitation label expansion, but readout to come sooner 
Endpoints
Mon, 02/27/23 - 10:19 am
Axsome Therapeutics
FDA
clinical trials
Alzheimer's disease agitation
Alzheimer's disease
AXS-05
Amid fentanyl crisis, first-of-its-kind study to evaluate expanded methadone access
Stat
Mon, 02/27/23 - 10:12 am
clinical trials
methadone
Fentanyl
opioids
Fulcrum's clinical hold caps off tough week for sickle cell drug development
Fierce Biotech
Sun, 02/26/23 - 10:20 pm
Fulcrum Therapeuticsl
FDA
sickle cell disease
clinical trials
FDX-6058
Novartis
Sangamo
Graphite Bio
Nektar's bitter pill: Phase 2 fail ends Lilly-partnered lupus program and prompts eczema rethink
Fierce Biotech
Fri, 02/24/23 - 09:27 am
Nektar Therapeutics
rezpegaldesleukin
clinical trials
lupus
BioCryst hits another hurdle, delays trial for its 1 remaining clinical candidate
Fierce Biotech
Fri, 02/24/23 - 08:58 am
Biocryst
BCX10013
complement-mediated diseases
clinical trials
Astellas Presents Update on Recently Cleared Pompe Gene Therapy Trial
BioSpace
Thu, 02/23/23 - 10:36 am
Astellas
Pompe disease
clinical trials
AT845
Gilead Sciences reports positive data from HIV therapy trial
Clinical Trials Arena
Thu, 02/23/23 - 10:12 am
Gilead Sciences
lenacapavir
HIV
clinical trials
Merck’s COVID-19 treatment falls short in prevention study
BioPharma Dive
Tue, 02/21/23 - 04:53 pm
Merck
COVID-19
Lagevrio
clinical trials
Aileron Terminates Phase 1b Breast Cancer Chemoprotection Trial Of ALRN-6924
NASDAQ
Tue, 02/21/23 - 04:34 pm
Aileron Therapeutics
clinical trials
breast cancer
ALRN-6924
Medivir completes initial Phase Ib part of HCC therapy trial
Clinical Trials Arena
Tue, 02/21/23 - 10:05 am
Medvir
fostrox
Lenvima
hepatocellular carcinoma
clinical trials
Takeda’s Vedolizumab Clears Phase III in aGvHD
BioSpace
Tue, 02/21/23 - 10:03 am
Takeda
vedolizumab
graft vs host disease
clinical trials
Delaying type 1 diabetes progression: major trial readouts to watch in 2023
Clinical Trials Arena
Mon, 02/20/23 - 12:54 pm
clinical trials
type 1 diabetes
Provention Bio
Tzeild
Diamyd Medical
remygen
Imcyse
IMCY-0098
ProKidney
Gilead reports positive data from urothelial cancer therapy trial cohorts
Clinical Trials Arena
Mon, 02/20/23 - 12:51 pm
Gilead Sciences
Trodelvy
metastatic urothelial cancer
clinical trials
Pfizer, Valneva remove half of participants from study of Lyme disease shot
BioPharma Dive
Fri, 02/17/23 - 11:27 am
Pfizer
Valneva
clinical trials
vaccines
Lyme disease
VLA15

Pages